Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Journal of Korean Medical Science ; : 104-106, 2012.
Article in English | WPRIM | ID: wpr-39057

ABSTRACT

We report on an angioedema patient with a genetic defect in complement 1 inhibitor, manifesting migraine-like episodes of headache, effective prophylaxis with Danazol, and triptan for a treatment of acute clinical episode. The patient was 44-yr-old Korean man with abdominal pain and headache, who was brought into the Emergency Department of Seoul National University Hospital, Seoul. He suffered from frequent attacks of migraine-like headache (3-7 per month), pulsating in nature associated with nausea. Severities were aggravated by activity and his headache had shown recent progression with abdominal pain. No remarkable findings were observed on radiologic examination, brain magnetic resonance images and intracranial and extracranial magnetic resonance angiography. Danazol 200 mg every other day was subsequently used. Following administration of Danazol, symptoms showed improvement and the patient was discharged. While taking Danazol, the migraine-like episodes appeared to be prevented for about 2 yr. At the eighth month, he suffered a moderate degree of migraine-like headache; however, administration of naratriptan 2.5 mg resolved his problem. A case of genetic defect of C1-INH deficiency presented with headache episodes, and was controlled by Danazol and triptan. It suggests that pathogenic mechanism of headache in hereditary angioedema may be mediated by the neurogenic inflammatory-like physiology of migraine.


Subject(s)
Adult , Humans , Male , Angioedemas, Hereditary/complications , Brain/diagnostic imaging , Complement C1 Inhibitor Protein/genetics , Danazol/therapeutic use , Estrogen Antagonists/therapeutic use , Magnetic Resonance Angiography , Migraine Disorders/diagnosis , Piperidines/therapeutic use , Tryptamines/therapeutic use , Vasoconstrictor Agents/therapeutic use
3.
Arq. neuropsiquiatr ; 67(2b): 559-569, June 2009. ilus, tab
Article in English | LILACS | ID: lil-519299

ABSTRACT

Triptans, serotonin 5-HT1B/1D receptor agonists, more than revolutionizing the treatment of migraine, stimulated also ground breaking research that provided insights into the anatomy, physiology, and molecular pharmacology of migraine. This knowledge, in turn, is stimulating research on new mechanisms of action for the treatment of migraine. Accordingly, it is opportune to critically review the main advances in migraine science that happened in the triptan era. Herein we first review and conceptualize some of the progresses achieved in migraine science during the triptan era. We then review the class of the triptans - mechanism of action and clinical evidence. We close by briefly discussing the class of CGRP receptor antagonists, which is currently being developed for the acute treatment of migraine.


Os triptanos, agonistas serotoninérgicos 5-HT1B/1D, revolucionaram o tratamento da migrânea promovendo pesquisas que evidenciaram aspectos da anatomia, fisiologia e farmacologia molecular deste tipo prevalente de cefaléia primária. Esse conhecimento, por sua vez vem estimulando ainda mais a descoberta de novos mecanismos de ação para drogas anti-migranosas. Assim, é oportuno rever de forma crítica, os maiores avanços na ciência das cefaléias ocorridos durante a era dos triptanos. Inicialmente reveremos e conceituaremos alguns dos progressos obtidos nesta fase seguido de uma revisão profunda dos mecanismos de ação e evidências clínicas para o uso desta classe de fármacos. Finalmente, discutiremos a nova classe dos antagonistas dos receptores do peptideo geneticamente relacionado à calcitonina (CGRP) atualmente em desenvolvimento.


Subject(s)
Humans , Migraine Disorders/drug therapy , Serotonin Receptor Agonists/therapeutic use , Tryptamines/therapeutic use , Clinical Trials as Topic
4.
Arch. invest. méd ; 21(2): 163-9, abr.-jun. 1990. ilus, tab
Article in Spanish | LILACS | ID: lil-177279

ABSTRACT

Se investigaron las propiedades de varios extractos de corteza de tepescohuite, Mimosa tenuiflora (Willd.) Poir. utilizando modelos biológicos in vitro, se observó que el extracto de acetato de etilo, cuyo contenido en taninos fue elevado, presentó actividad antimicrobiana; el extracto butanólico, rico en alcaloides, modificó de manera importante la excitabilidad de la musculatura lisa. Los extractos butanólico y metanólico produjeron hemólisis, posiblemente atribuible a su contenido en saponinas. Se discute la variedad de compuestos con propiedades biodinámicas que contiene este producto natural


Subject(s)
Alkaloids/analysis , Alkaloids/therapeutic use , In Vitro Techniques , Medicine, Traditional , Tryptamines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL